Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Types

    ... divides MDS in to five subtypes based on percentage of blasts in the bone marrow and the peripheral blood. It is now used ... FAB-type % blasts in blood % blasts in bone marrow ...

    Topic section last updated 05/16/2018 - 11:26am.

  2. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... We propose to enroll patients with MDS who have excess blasts (5% to 30% BM blasts), and have progressed during, failed to respond to, are intolerant of, ...

    Clinical Trial last updated 05/04/2018 - 3:53pm.

  3. MDS - Basics

    ... Blast Counts Blasts are very young or immature white blood cells. In normal bone marrow , no more than 5 out of 100 white cells are blasts. Because people with MDS may have too many bone marrow blasts, doctors ...

    Topic section last updated 05/04/2018 - 1:44pm.

  4. Retired MDS Patient Living Life to the Fullest Since Transplant

    ... stage was Refractory Anemia with Excess Blasts (RAEB-1) with one chromosomal abnormality. In February 2010, I ...

    Patient Chronicle last updated 04/26/2018 - 10:43am.

  5. A Phase 2 Study of Tipifarnib in Subjects with Chronic Myelomonocytic Leukemia

    ... to acute myeloid leukemia (AML) defined by at least 20% blasts in the blood or bone marrow . ...

    Clinical Trial last updated 04/23/2018 - 2:51pm.

  6. Treatments

    ... abnormal bone marrow cells  Reduce the number of  blasts  (young white blood cells) in your bone marrow that have an abnormal ...

    Topic section last updated 04/06/2018 - 12:30pm.

  7. A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes.

    ... with ringed sideroblasts (RARS) or RA with excess blasts (RAEB)/RAEB in transformation (RAEBt), respectively. Our results ...

    Research Article last updated 12/19/2017 - 2:05pm.

  8. Allogeneic Hematopoietic Stem Cell Transplantation is Underutilized in Older Patients with Myelodysplastic Syndromes

    ... (p=0.008), intermediate-1/low risk MDS (p<0.001), <5% blasts at diagnosis (overall p<0.001), having medicare/medicaid health ... between 2008-2011 (p<0.001), age ≥65 (p=0.001) and <5% blasts at diagnosis (overall p=0.031) were associated with a lower likelihood ...

    Research Article last updated 04/14/2017 - 9:28am.

  9. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes.

    ... of dysplasia (such as ring sideroblasts or excess of blasts ). Therefore, there is clearly need to refine the accuracy to detect ...

    Research Article last updated 03/22/2017 - 9:18am.

  10. Outcome of patients treated for myelodysplastic syndromes without deletion 5q after failure of lenalidomide therapy

    ... analysis, adverse cytogenetics , excess of blasts at the initiation of LEN, and the type of failure (classified as ...

    Research Article last updated 02/21/2017 - 9:43am.